www.genethique.org

Bioethic information and analysis newsletter

Previous letter Previous Letter

Following Letter

Following Letter

N°66 - June 2005

The Newsletter index
France: Bill on therapeutic cloning
Referendum in Italy: the law on medically assisted reproduction is maintained
Abortion and later risk of preterm birth
 

France: Bill on therapeutic cloning

First human cloning?
In May 2005, Pr Woo Suk Hwang’s Korean team announced to have succeeded in cultivating eleven stem cell lines obtained from cloned embryos, which are cells susceptible to differentiate into various tissues. Korean researchers, embarrassed by the designation "cloning" prefer to talk about “production of embryonic stem cell lines by nuclear transfer”.
Immediately, the ex-minister for Research Roger-Gérard Schwartzenberg, today deputy, introduced a bill for authorising researches on therapeutic cloning in France.

The Bill
In order neither to "not hamper the French researchers" nor "to disadvantage ill patients", the bill sets as a principle to authorize, by supervising them, researches on therapeutic cloning.
For M. Schwartzenberg, the stem cell graft obtained from embryos developed in vitro and which are not subject to a parental project (which it is authorized in France exceptionally since the law of August 2004 of which the application decrees are foreseen for Autumn 2005 and are already practised on imported embryonic stem cell lines), may cause rejection phenomenon. Only stem grafts obtained by cloning would allow avoiding immunologic rejection. Cloning would allow constituting cell lines totally compatible with the immune system of the patient, donor of the nuclei. Although most of researchers acknowledge that there is still a lot of work to do in order to pass from comprehension of pathologic living organisms to the possibility to cure them, this bill is supported by four French scientists, Professors Beaulieu, Fischer, Frydman and Peschanski.

Embryo and politic
Mr Schwartzenberg does not take into account the ethical arguments estimating that “in a laic republic, the legislator cannot transform a faith article into a law”, considering that the fact to confer a sacred character to “an assembly of 125 cells still undifferentiated” “depends on spiritual or philosophic convictions of each other”...
In the exposition of motives and relying on the text of the Treaty establishing a Constitution for Europe, Mr. Schwartzenberg indicates that “in its article II-63, the Chart of fundamental rights, integrated to this treaty, only prohibits human reproductive cloning, but not therapeutic cloning. If the ratification of this treaty by France is authorized by the referendum of 29 May 2005, this treaty will have an authority above the laws, in accordance with the article 55 of French Constitution of 1958.”
French bioethics law could even be illegal in the Union: “dispositions of French law of 6 August 2004 prohibiting therapeutic cloning could be censured by the European Court of Justice”. “As expressly reminded by the I-6 of the European Constitution, the law of European Union shall have primacy over the law of the Member States".

Cloning: scientific advance?
Therapeutic cloning only aims to obtain embryonic stem cells in order to find new therapies. But:
- The therapy with embryonic stem cells does not give results.
In Great Britain, research on embryos is authorised for 15 years: it does not give any therapeutic result.
- its promoters try to justify it announcing that it will allow them to obtain embryonic stem cells compatible with the recipient organism, of whom the clone was taken from. But researches show that injected embryonic stem cells, whatever their origin (taken from a supernumerary embryo for instance) are not rejected. So it is not necessary to perform cloning to create an embryo "compatible" with the donor.
Cloning is dangerous:
- Embryonic stem cells taken from and then rejected are not controllable. Because of its extraordinary potential of differentiation, the recipient organism does not know how to control their development. They convert into tumoral cells, unlike controlled adult stem cells.
- 100% of clones (animals) are abnormal, so their cells too...
For Carine Camby, director-general of the recent French Biomedicine Agency, there is no hurry. "If we have to make a new decision, this cannot be done under the pressure of a scientific publication, even if it is interesting."

Reproductive cloning
Following Unesco report of August 2004, scientists recognize that there is no possible therapeutic research on embryonic cells, obtained or not by cloning, and today use the term of "research cloning". Even if this cloning is called research, scientific, therapeutic or reproductive cloning, it is, in all cases, reproductive as it involves the conception of a human being
. .

To the top of the page

 

Referendum in Italy: the law on medically assisted reproduction is maintained

The 11 and 12 last June, in Italy, citizens were called on to abrogate by referendum, some measures of the law 40 relative to assisted procreation, in other words, to liberalize research on embryo and procreation medical techniques. It required 50% + 1 vote of participation so that the vote was valid. The opponents of the referendum asked for abstention. Less than 26% of the voters went to vote. The law of February 2004 supervising rigorously resort conditions to AMP and foreseeing protective measures for the embryo (Gènéthique n°52) will not be modified.

The genesis of the law 40
On 10 February 2004 Italian Parliament approved a bill prohibiting the experimentation on embryo, their freezing, the resort to sperm or oocyte donors as well as surrogate mothers. It also restraints the medically assisted procreation to "stable" heterosexual couples. The final bill is passed with a large majority. Participants to the law are pleased then to put an end to 25 years of drifts in fertility medicine, in this country which allowed a 62 year-old Roman woman to have a baby and which let Dr Antinori announce the launching of a program to clone babies. It became urgent for Italy to restore clearly rules regarding bioethics.
The law 40 sets as a principle that all embryos have the right to live and that they cannot be eliminated or used as research material. Methods of medically assisted procreation must respect this principle. It is allowed to conceive by fertilization in vitro a maximum of three embryos. These have to be immediately transferred. If this decision allows mother health to be respected, it also avoids the “supernumerary” embryo freezing. The absence of frozen embryo stock is the more reliable solution to prevent research on embryos.

Political battle
Just once voted, this law was judged to be too restrictive by the opponents who endeavoured to abrogate it. The radical party regroups the 800,000 signatures required to obtain from the government the calling for parliamentary referendum.

The third vote: the abstention
Reactions are complicated in the side of those who want to preserve the law 40 because they can vote "no" but they can also abstain. If the quorum of voters is not reached, the referendum is annulled and the law 40 is not modified. The abstention became de facto a possible and efficient mode of expression, a third electoral voice. Manifestations and TV spots urged not to vote. "Life cannot be voted, choose not to vote"...

The Church: for a political realism
If the law 40 is not perfect for Catholics, since it authorizes fertilization in vitro, but yet it will find from them its main supporters, because the essential is preserved: the dignity of the embryo is recognized and defended. In this context, the intervention of the Church is of growing interest. Cardinal Ruini, president of the Episcopal Conference, calls Italian citizens not to vote. It is not to give their commitment into political life, he specified, but at the contrary to show a political realism. In a speech directed to Episcopal conference the Pope Benedict XVI officially supported the call of the bishops: "within such a commitment, I am close by the word and pray."

None compromise
This very striking speech is not amazing when we remind the "Doctrinal note about participation of Catholics in political life" (Nov. 2002) by Cardinal Ratzinger. Passed over in silence in France, it clearly redefines the share of roles. Rightful autonomy is only justified if it is understood as "autonomy of the political or civil sphere from that of religion and the Church", “but not from that of morality". Catholics have “a grave and clear obligation to oppose any law that attacks”.

To the top of the page

 

Abortion and later risk of preterm birth

A study, carried out by Doctor Caroline Moreau’s team in the framework of Inserm Epipage group1, analyses the risk of preterm birth associated to a precedent induced abortion and analyses the causes. This inquest was made in 1997 and lists the preterm births in maternity hospital from nine French regions, representing one third of births. In France, 60% of women who abort have less than 30 years and most of them would like to have a baby after one or several abortions. What will their obstetrical future be?

Increasing of preterm births
The relation between a former abortion and preterm birth is more frequent for the very preterm delivery (between 22 and 27 pregnancy weeks) and the risk increases with the number of elective abortions. Before 28 weeks, the more frequent cause is haemorrhage (placenta previa or rupture of placenta), the preterm rupture of membranes or the spontaneous idiopathic preterm labour. After 28 weeks, the more frequent cause of preterm births is hypertension and the defect of foetus growth and the relation with abortion is not significant.
This study confirms the results of previous European inquests which suggested that women who experienced an abortion presented a higher risk of amniotic liquid infection generating a preterm rupture of membranes as well as cervical and uterine abnormalities generating a preterm birth.

1- Previous induced abortions and the risk of very preterm delivery: results of the EPIPAGE study, BJOG 2005 Apr.; vol.112, p.430
 

To the top of the page

 

  is a monthly newsletter, distributed free of charge, and published by the Jérôme Lejeune Foundation. Director of the Publication : Jean-Marie Le Méné - Editor in chief : Aude Dugast
31 rue Galande - 75005 Paris - France - Tel : +33 (0)1.55.42.55.14 - ISSN 1638-198 X
contact@genethique.org

 

Subscribe today to weekly Press Review or monthly Newsletter, it's free!

 

Traduction by A.R-TRADUCTION